ESC 2018 preview – A possible boost for Abbott, and balloons go up against stents
In a quiet year for medical devices a couple of studies are still worth watching.
Medtechs prioritise efficiency when it comes to hiring
Big cap medtech is hiring, largely thanks to organic growth.
M&A comes back with a bang – or two – in medtech
The preponderance of large deals comes partly as a consequence of soaring market valuations; paradoxically, it is also a cause of them.
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.